Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.
Bartolomeo R, Troise F, Allocca S, Sdruscia G, Vitale R, Bignone V, Petrone AM, Romano G, D'Alise AM, Ruzza V, Garzia I, Leoni G, Merone R, Lanzaro F, Colloca S, Siani L, Scarselli E, Cotugno G.
Bartolomeo R, et al. Among authors: cotugno g.
Vaccines (Basel). 2024 Mar 19;12(3):325. doi: 10.3390/vaccines12030325.
Vaccines (Basel). 2024.
PMID: 38543959
Free PMC article.